InVentiv Sees More Opportunities To Serve Pharma As Private Vs. Public Company
This article was originally published in The Pink Sheet Daily
Executive Summary
Private equity firm Thomas H. Lee Partners agrees to acquire contract sales and services company inVentiv Health for $1.1 billion.
You may also be interested in...
PDI Buys Group DCA, An E-Promotion Company
PDI, one of the pharma industry's major contract sales organizations, is acquiring an interactive, digital communications company, as part of a broader overhaul of its business.
PDI Buys Group DCA, An E-Promotion Company
PDI, one of the pharma industry's major contract sales organizations, is acquiring an interactive, digital communications company, as part of a broader overhaul of its business.
Assessing REMS: Risk Management's Key Question -- Do The Programs Work?
The first stage of REMS implementation from March 2008 until December 2009 was relatively easy. FDA and drug sponsors leaqrned how to adapt existing communications programs and techniques to deliver new safety messages. Now both the agency and the sponsors are moving into new territory: evaluating REMS. Both are grappling with the challenge of how to show that programs are working.